Purdue Pharma's chairman says the company should still produce OxyContin despite the drugmaker's bankruptcy filing amid the opioid crisis.
Purdue Pharma chair: Best way to fight opioid crisis is for OxyContin maker to stay in business - CNBC
Read More
Bagikan Berita Ini
0 Response to "Purdue Pharma chair: Best way to fight opioid crisis is for OxyContin maker to stay in business - CNBC"
Post a Comment